Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine.
作者信息
Watabe Daisuke, Tsunoda Kanako, Amano Hiroo
机构信息
Department of Dermatology, Iwate Medical University School of Medicine, 2-1-1, Idaidori, Yahabacho, Iwate 028-3695, Japan
出版信息
Eur J Dermatol. 2022 May 1;32(3):420-421. doi: 10.1684/ejd.2022.4285.
Abstract
摘要
相似文献
1
Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine.第二剂BNT162b2新冠mRNA疫苗接种后银屑病关节炎发作
Eur J Dermatol. 2022 May 1;32(3):420-421. doi: 10.1684/ejd.2022.4285.
2
Psoriasis flare-up after AZD1222 and BNT162b2 COVID-19 mRNA vaccines: report of twelve cases from a single centre.接种AZD1222和BNT162b2新冠mRNA疫苗后银屑病发作：来自单一中心的12例报告
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e411-e415. doi: 10.1111/jdv.17965. Epub 2022 Feb 4.
3
Commentary on 'Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine'.关于“第二剂辉瑞 - 生物科技公司BNT16B2b2 COVID - 19 mRNA疫苗引发银屑病”的评论
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e606. doi: 10.1111/jdv.18117. Epub 2022 Apr 22.
4
A case of psoriatic spondyloarthritis exacerbation triggered by COVID-19 messenger RNA vaccine.1例由新型冠状病毒肺炎信使核糖核酸疫苗引发的银屑病关节炎加重病例。
J Eur Acad Dermatol Venereol. 2022 Jun;36(6):e427-e429. doi: 10.1111/jdv.18013. Epub 2022 Feb 23.
5
A Case of Myocarditis Presenting With a Hyperechoic Nodule After the First Dose of COVID-19 mRNA Vaccine.接种首剂 COVID-19 mRNA 疫苗后出现心肌炎并伴有高回声结节 1 例
J Korean Med Sci. 2022 Apr 25;37(16):e131. doi: 10.3346/jkms.2022.37.e131.
6
Eosinophilic cellulitis in response to BNT162b2 COVID-19 vaccination.对 BNT162b2 COVID-19 疫苗接种的嗜酸性蜂窝织炎反应。
Pediatr Dermatol. 2022 Sep;39(5):823-824. doi: 10.1111/pde.15019. Epub 2022 May 6.
7
Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis.一名银屑病患者接种第一剂辉瑞-生物科技公司BNT16B2b2 COVID-19 mRNA疫苗后出现红皮病。
Dermatol Ther. 2022 May;35(5):e15363. doi: 10.1111/dth.15363. Epub 2022 Feb 14.
8
Meta-Analysis of Risk of Myocarditis After Messenger RNA COVID-19 Vaccine.信使核糖核酸新冠疫苗接种后心肌炎风险的Meta分析
Am J Cardiol. 2022 Mar 15;167:155-157. doi: 10.1016/j.amjcard.2021.12.007. Epub 2022 Jan 19.
9
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study.ChAdOx1-S 和 BNT162b2 或 mRNA-1273 疫苗异源初免和加强接种的安全性：全国队列研究。
BMJ. 2022 Jul 13;378:e070483. doi: 10.1136/bmj-2022-070483.
10
Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.川崎病病史患者对 COVID-19 感染和信使 RNA 疫苗接种的耐受性。
JAMA Netw Open. 2022 Aug 1;5(8):e2226236. doi: 10.1001/jamanetworkopen.2022.26236.
引用本文的文献
1
New-Onset Psoriatic Arthritis Following COVID-19 mRNA Vaccination in a Psoriatic Patient Under Anti-tumor Necrosis Factor Alpha Biologic Treatment: What Now?一名接受抗肿瘤坏死因子α生物制剂治疗的银屑病患者在接种新冠病毒mRNA疫苗后出现新发银屑病关节炎：现在该怎么办？
Cureus. 2023 Dec 18;15(12):e50723. doi: 10.7759/cureus.50723. eCollection 2023 Dec.
2
Drug- or Vaccine-Induced/Aggravated Psoriatic Arthritis: A Systematic Review.药物或疫苗诱发/加重的银屑病关节炎：一项系统综述
Dermatol Ther (Heidelb). 2024 Jan;14(1):59-81. doi: 10.1007/s13555-023-01082-z. Epub 2024 Jan 6.
本文引用的文献
1
Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine.新冠疫苗加重的急性泛发性脓疱型银屑病
JAAD Case Rep. 2021 Nov;17:1-3. doi: 10.1016/j.jdcr.2021.08.035. Epub 2021 Sep 9.
2
Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.成人系统性风湿病患者 COVID-19 疫苗接种的早期经验：来自 COVID-19 全球风湿病联盟疫苗调查的结果。
RMD Open. 2021 Sep;7(3). doi: 10.1136/rmdopen-2021-001814.
3
COVID-19 vaccine safety and efficacy in patients with immune-mediated inflammatory disease: Review of available evidence.COVID-19 疫苗在免疫介导的炎症性疾病患者中的安全性和有效性：现有证据综述。
J Am Acad Dermatol. 2021 Nov;85(5):1274-1284. doi: 10.1016/j.jaad.2021.07.054. Epub 2021 Aug 4.
4
Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre.新冠病毒疫苗接种后银屑病病情加重：来自单一中心的14例报告。
J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e857-e859. doi: 10.1111/jdv.17582. Epub 2021 Aug 20.
5
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.风湿和肌肉骨骼疾病患者在接受两剂 SARS-CoV-2 信使 RNA 疫苗接种后的疾病发作和反应原性。
Arthritis Rheumatol. 2022 Jan;74(1):28-32. doi: 10.1002/art.41924. Epub 2021 Dec 3.
6
Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2.炎症性风湿病患者接种两剂辉瑞 SARS-CoV-2 mRNA 疫苗后的疾病活动和体液反应。
Ann Rheum Dis. 2021 Oct;80(10):1317-1321. doi: 10.1136/annrheumdis-2021-220503. Epub 2021 Jun 18.
7
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.报告的 Moderna 和辉瑞 COVID-19 疫苗接种后皮肤反应：基于登记的 414 例病例研究。
J Am Acad Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7.
8
COVID-19 vaccines: modes of immune activation and future challenges.COVID-19 疫苗：免疫激活模式和未来挑战。
Nat Rev Immunol. 2021 Apr;21(4):195-197. doi: 10.1038/s41577-021-00526-x.
9
Coronavirus vaccine development: from SARS and MERS to COVID-19.冠状病毒疫苗的研发：从 SARS 和 MERS 到 COVID-19。
J Biomed Sci. 2020 Dec 20;27(1):104. doi: 10.1186/s12929-020-00695-2.
Zotero 插件